Separately, Eight Capital restated a buy rating and issued a C$9.00 price objective on shares of Aurora Cannabis in a report on Thursday, August 2nd.
Shares of TSE ACB opened at C$12.19 on Wednesday. Aurora Cannabis has a fifty-two week low of C$2.65 and a fifty-two week high of C$15.20.
Aurora Cannabis Company Profile
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution.
Featured Story: What is a Tariff?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.